Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $253.30 | Total: $1,266.50 |
| 1 | 10 | $214.56 | Total: $2,145.60 |
| 1 | 25 | $181.78 | Total: $4,544.50 |
| 1 | 50 | $154.96 | Total: $7,748.00 |
| 1 | 100 | $134.10 | Total: $13,410.01 |
Overview
UB 165 fumarate is an agonist of the nAChR, a partial agonist of the ?4?2 subtype, and a full agonist of the ?3?2 subtype, with a Ki value of 0.27 nM for binding to [3H]-nicotine measured in rat brain.
Chemical Properties
| Molecular Formula | C17H19ClN2O4 |
| Molecular Weight | 350.8 |
| CAS Numbers | 2454492-43-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(=CC(O)=O)C(O)=O.ClC=1C=CC(C=2[C@@]3(N[C@@](CC3)(CCC2)[H])[H])=CN1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Sharples CG, et al. UB-165 a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci. 2000 Apr 15;20[8] 2783-91.